Treating bony metastases.

This publication has 26 references indexed in Scilit:

• LONG-TERM EFFECTS OF PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CL2MBP) ON BONE DISEASE OF MYELOMA PATIENTS TREATED WITH CHEMOTHERAPY
  Hematological Oncology, 1990
• Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.
  BMJ, 1988
• Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy
  BMJ, 1988
• Evaluation of salmon calcitonin treatment in bone metastases from breast cancer-a controlled trial
  Bone, 1988
• Treatment of metastatic bone pain with strontium-89
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
• Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.
  BMJ, 1987
• REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT
  The Lancet, 1987
• Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells
  New England Journal of Medicine, 1987
• DIPHOSPHONATES FOR OSTEOLYTIC METASTASES
  The Lancet, 1985
• Incidence of Fracture Through Metastases in Long Bones
  Acta Orthopaedica, 1981